Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Waxman

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Cancer Journal (Sudbury, Mass.)|March 16, 2002
Arsenic trioxide in multiple myeloma: rationale and future directionsKenneth C Anderson, Lawrence H Boise, Robert Louie, et al.
Blood|January 1, 2004
JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cellsKelly Davison, Koren K Mann, Samuel Waxman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2015
Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML CellsRui Wang, Lijuan Xia, Janice Gabrilove, et al.
Cancer Biology & Therapy|August 17, 2012
CD44 ligation with A3D8 antibody induces apoptosis in acute myeloid leukemia cells through binding to CD44s and clustering lipid raftsHao Qian, Lijuan Xia, Peixue Ling, et al.
Cancer Research|December 6, 2006
Targeted degradation of the AML1/MDS1/EVI1 oncoprotein by arsenic trioxideDavid Shackelford, Candia Kenific, Agnieszka Blusztajn, et al.
Blood|July 3, 2004
Glutathione-S-transferase pi inhibits As2O3-induced apoptosis in lymphoma cells: involvement of hydrogen peroxide catabolismLi Zhou, Yongkui Jing, Miroslav Styblo, et al.
Molecular Cancer Therapeutics|November 9, 2005
Clinical translation of epigenetics in cancer: eN-CORe--a report on the second workshopArthur Zelent, Kevin Petrie, Reuben Lotan, et al.
Molecular Cancer Therapeutics|March 16, 2005
Boswellic acid acetate induces apoptosis through caspase-mediated pathways in myeloid leukemia cellsLijuan Xia, Duo Chen, Rui Han, et al.
Molecular Cancer Therapeutics|July 1, 2018
Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia CellsRui Wang, Ying Li, Ping Gong, et al.
Cells|April 12, 2022
The Sin3A/MAD1 Complex, through Its PAH2 Domain, Acts as a Second Repressor of Retinoic Acid Receptor Beta Expression in Breast Cancer CellsNisha Rani Dahiya, Boris A Leibovitch, Rama Kadamb, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Cancer Journal (Sudbury, Mass.)|March 16, 2002
Arsenic trioxide in multiple myeloma: rationale and future directionsKenneth C Anderson, Lawrence H Boise, Robert Louie, et al.
Blood|January 1, 2004
JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cellsKelly Davison, Koren K Mann, Samuel Waxman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2015
Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML CellsRui Wang, Lijuan Xia, Janice Gabrilove, et al.
Cancer Biology & Therapy|August 17, 2012
CD44 ligation with A3D8 antibody induces apoptosis in acute myeloid leukemia cells through binding to CD44s and clustering lipid raftsHao Qian, Lijuan Xia, Peixue Ling, et al.
Cancer Research|December 6, 2006
Targeted degradation of the AML1/MDS1/EVI1 oncoprotein by arsenic trioxideDavid Shackelford, Candia Kenific, Agnieszka Blusztajn, et al.
Blood|July 3, 2004
Glutathione-S-transferase pi inhibits As2O3-induced apoptosis in lymphoma cells: involvement of hydrogen peroxide catabolismLi Zhou, Yongkui Jing, Miroslav Styblo, et al.
Molecular Cancer Therapeutics|November 9, 2005
Clinical translation of epigenetics in cancer: eN-CORe--a report on the second workshopArthur Zelent, Kevin Petrie, Reuben Lotan, et al.
Molecular Cancer Therapeutics|March 16, 2005
Boswellic acid acetate induces apoptosis through caspase-mediated pathways in myeloid leukemia cellsLijuan Xia, Duo Chen, Rui Han, et al.
Molecular Cancer Therapeutics|July 1, 2018
Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia CellsRui Wang, Ying Li, Ping Gong, et al.
Cells|April 12, 2022
The Sin3A/MAD1 Complex, through Its PAH2 Domain, Acts as a Second Repressor of Retinoic Acid Receptor Beta Expression in Breast Cancer CellsNisha Rani Dahiya, Boris A Leibovitch, Rama Kadamb, et al.
Pageof 8